2020 ASCO Virtual Direct™ Highlights

 

GU
08:02

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mUC: Can Tumor Microenvironment Biomarkers Help Predict Which Patients May Derive Greater Benefit from Upfront Anti-PD-L1 Therapy With Atezolizumab?

FEATURING David Quinn
  • 214 views
  • August 13, 2020
06:18

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: Is Nivo Monotherapy Active in Treatment Naive ccRCC?

FEATURING David Quinn
  • 81 views
  • August 24, 2020
09:35

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced RCC: 1L Pembro + Axitinib vs. Sunitinib - Which Option Has Superior and Durable Antitumor Activity?

FEATURING David Quinn
  • 339 views
  • August 13, 2020
  • 2
10:31

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Urothelial Cancer: Maintenance Avelumab + BSC vs BSC Alone - Does Avelumab 1L Maintenance Represent a Paradigm Shift for Clinical Practice?

FEATURING David Quinn
  • 176 views
  • August 13, 2020
09:43

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Delivery of ADT in Advanced Prostate Cancer: Relugolix vs. Leuprolide Acetate - Which Option Is Superior?

FEATURING Hala Borno
  • 126 views
  • August 24, 2020
08:38

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Molecular Imaging in Prostate Cancer: Is 18F-DCFPyL-PET/CT Superior to Standard Imaging in Men w/ BCR? Is 68Ga-PSMA-11 Accurate in Pelvic Nodal Metastasis Detection?

FEATURING Hala Borno
  • 128 views
  • August 24, 2020
  • 1
09:15

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on nmCRPC: Does the Utilization of Early AR Antagonism Prolong Survival?

FEATURING Hala Borno
  • 79 views
  • August 13, 2020